Antimicrobial activity of ceftolozane/tazobactam tested against Pseudomonas aeruginosa and Enterobacteriaceae with various resistance patterns isolated in European hospitals (2011–12) | Zendy

Hélio S. Sader | Zendy; David J. Farrell | Zendy; Mariana Castanheira | Zendy; Robert K. Flamm | Zendy; Ronald N. Jones | Zendy

Open Access

Antimicrobial activity of ceftolozane/tazobactam tested against Pseudomonas aeruginosa and Enterobacteriaceae with various resistance patterns isolated in European hospitals (2011–12)

Author(s) -

Hélio S. Sader,

David J. Farrell,

Mariana Castanheira,

Robert K. Flamm,

Ronald N. Jones

Publication year - 2014

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dku184

Subject(s) - broth microdilution , meropenem , microbiology and biotechnology , ceftazidime , pseudomonas aeruginosa , tigecycline , colistin , tazobactam , ceftazidime/avibactam , cephalosporin , biology , antimicrobial , minimum inhibitory concentration , antibiotics , medicine , imipenem , antibiotic resistance , bacteria , genetics

To evaluate the in vitro activity of ceftolozane/tazobactam and comparator agents tested against contemporary Gram-negative bacteria. Ceftolozane/tazobactam is an antipseudomonal cephalosporin combined with a well-established β-lactamase inhibitor.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research